Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Roehrborn, C. G. Pathology of benign prostatic hyperplasia. International journal of impotence research 20(Suppl 3), S11–18, doi: 10.1038/ijir.2008.55 (2008).
2. Speakman, M., Kirby, R., Doyle, S. & Ioannou, C. Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK. BJU international 115, 508–519, doi: 10.1111/bju.12745 (2015).
3. Rawson, N. S. & Saad, F. The aging male population and medical care for benign prostatic hyperplasia in Canada. Canadian Urological Association journal=Journal de l’Association des urologues du Canada 4, 123–127 (2010).
4. McVary, K. T. et al. Update on AUA guideline on the management of benign prostatic hyperplasia. The Journal of urology 185, 1793–1803, doi: 10.1016/j.juro.2011.01.074 (2011).
5. Von Heland, M. & Casale, P. Role of alpha blockers in the treatment of BPH: a critical review of clinical results. Archivos espanoles de urologia 47, 873–881, discussion 881–872 (1994).
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献